FDA Recalls Neonatal TPN Starter Bags for Sterility Concerns
Central Admixture Pharmacy Services recalls 747 bags of Neonatal TPN Starter Bags due to FDA sterility concerns. Products were distributed nationwide across the USA.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product (intravenous nutrition for vulnerable neonates) where no illnesses or injuries have been reported. The lack of sterility assurance in an injectable product intended for vulnerable patients represents significant potential for infection.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 747 bags of Neonatal TPN Starter Bag (Amino Acids [Trophamine] 4% / Dextrose 10% with Calcium and Heparin, 250 mL per bag, NDC 71285-0422-1) distributed nationwide. The recall was initiated following an FDA inspection that called into question the sterility assurance of these intravenous nutrition products.
The affected lots with their expiration dates are: 37-893819 (04/28/2023), 37-894702 (04/30/2023), 37-894710 (04/30/2023), 37-895215 (05/04/2023), 37-897282 (05/12/2023), 37-897921 (05/13/2023), 37-898309 (05/14/2023), 37-899199 (05/19/2023), and 37-900058 (05/21/2023). The products are manufactured by Central Admixture Pharmacy Services, Inc., located at 6580 Snowdrift Road, Allentown, Pennsylvania 18106.
Healthcare providers and patients should verify whether they have received any of these recalled products. These are prescription-only products intended for intravenous use in neonatal patients. If any of the affected lots have been dispensed, they should not be used. Patients and healthcare providers should contact their healthcare provider or the manufacturer with questions or concerns.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4%/Dextrose 10% with CALCIUM and HEPARIN, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0422-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Parenteral Nutrition
- Affected units
- 747
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (17)
- Lot # 37-893819
- Exp 04/28/2023
- 37-894702
- 37-894710
- Exp 04/30/2023
- 37-895215
- Exp 05/04/2023
- 37-897282
- Exp 05/12/2023
- 37-897921
- Exp 05/13/2023
- 37-898309
- Exp 05/14/2023
- 37-899199
- Exp 05/19/2023
- 37-900058
- Exp 05/21/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 108 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 108 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15